HEATHER MIXSON: Open Payments
NPI 1447296108 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,265 in 141 payments from 48 companies in 2025. Trend: 2023 $3,619 · 2024 $3,672 · 2025 $4,265
Food & beverage: $3,766Long term medical supply or device loan: $499
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $781 |
| Daiichi Sankyo Inc. | 7 | $301 |
| Incyte Corporation | 8 | $218 |
| GlaxoSmithKline, LLC. | 6 | $197 |
| Merck Sharp & Dohme LLC | 7 | $183 |
| GENZYME CORPORATION | 3 | $174 |
| AstraZeneca Pharmaceuticals LP | 7 | $160 |
| Janssen Biotech, Inc. | 6 | $143 |
| E.R. Squibb & Sons, L.L.C. | 6 | $124 |
| SANOFI US SERVICES INC. | 1 | $121 |
Products named: KISQALI, DATROWAY, KEYTRUDA, SARCLISA, AYVAKIT, JAKAFI, REBLOZYL, MYRISK.
Industry payments across FL — which companies pay providers there.
